Navigation Links
Gentium's Defibrotide Highlighted in Two Poster Presentations at,American Association for Cancer Research Annual Meeting

VILLA GUARDIA (COMO), Italy--(BUSINESS WIRE)--Apr 13, 2007 - Gentium, S.p.A. (NASDAQ:GENT) (the "Company") today reported that its lead investigational product, Defibrotide, will be the subject of two poster presentations at the American Association for Cancer Research's (AACR) Annual Meeting being held at the Los Angeles Conference Center in Los Angeles, California, from April 14-18, 2007.

On Monday, April 16, 2007, from 1:00 p.m. to 5:00 p.m. (Pacific Time), Dr. Cinara Echart, Ph.D., Manager of Biological Research Laboratory at Gentium, will present a poster entitled "Modulation Of Heparanase Expression In Myeloma Tumor Cell Lines By Defibrotide: A Novel Mechanism Of Anti-Tumor Activity." (Poster session 23, Tumor Biology 21, Abstract #3100, Board #29)

Elevated heparanase expression in humans has been correlated with advanced progression and metastasis of many tumor types, including multiple myeloma (MM), where its presence may be particularly important because MM expresses high levels of heparin sulphate proteoglycan syndecan-1(CD138).

This in vitro study investigated Defibrotide's effectiveness in regulating the expression and activity of heparanase in two MM cell lines, U266 and RPMI 8226. The potential effect of Defibrotide to regulate heparanase gene expression was evaluated through real time polymerase chain reaction (RT-PCR) of cDNA prepared from the two lines of MM cells treated with Defibrotide or saline. Heparanase activity was measured in MM cells treated with Defibrotide (at 50, 100 and 150 (mu)g/ml) or saline for 24 hours by using a heparan-degrading enzyme kit. Results showed a significant down-regulation of heparanase gene expression by Defibrotide (at 150 (mu)/ml) after 24 hours of treatment (p less than 0.01) compared with saline.

Dr. Echart expounded upon these results, "These pre-clinical data suggest that Defibrotide not only has an effect in down-regulation of heparan
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Gentiums Defibrotide Seen as Active in Multiple Myeloma
2. Gentiums Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
3. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
4. Isotechnikas Lead Drug, ISA247, To Be Highlighted at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
5. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
6. Alfacells Onconase Highlighted in Latest Edition of Handbook of Therapeutic Antibodies
7. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
8. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
9. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
10. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
11. Savient Pharmaceuticals Announces Acceptance of Two Gout-Related Abstracts for Poster Presentation at the European League Against Rheumatism (EULAR) 2007 Annual Congress
Post Your Comments:
(Date:4/30/2015)... April 30, 2015  Thoratec Corporation (NASDAQ: THOR ... to save, support and restore failing hearts, said today ... Lynch 2015 Healthcare Conference on Thursday, May 14. ... Executive Officer, will provide an update on the company, ... Eastern Daylight Time). The presentation will be ...
(Date:4/30/2015)... -- DURECT Corporation (Nasdaq: DRRX ) announced today financial ... were $4.8 million and net loss was $4.9 million ... compared to total revenues of $6.3 million and net ... March 31, 2014.At March 31, 2015, we had cash ... investments of $34.9 million at December 31, 2014.  Subsequent ...
(Date:4/30/2015)... Company plc (NYSE: PRGO ; TASE) today announced that Perrigo ... at the 2015 Deutsche Bank 40 th Annual Healthcare Conference ... Hotel in Boston , MA.  ... Joseph C. Papa will present at the Bank of America ... 12, 2015 at the Encore at Wynn Las Vegas Hotel in ...
Breaking Medicine Technology:Thoratec Presentation At Bank Of America Merrill Lynch Healthcare Conference To Be Webcast 2DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 8DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 9Perrigo Company To Present At Upcoming Healthcare Conferences 2Perrigo Company To Present At Upcoming Healthcare Conferences 3
... April 12, 2011 Havel,s market leading EchoStim® ... allows practitioners to perform Peripheral Nerve Blocks (PNBs) ... same time.  The new improved needle has more, ... ultrasound easier, giving even inexperienced practitioners the benefits ...
... April 12, 2011 Perrigo (Nasdaq: PRGO ; ... and Drug Administration (FDA) has concluded its re-inspection of Perrigo,s ... the Company has an acceptable regulatory status, such that any ... once again be eligible for review and approval. ...
Cached Medicine Technology:Perrigo Announces Conclusion of the FDA Re-Inspection 2
(Date:5/2/2015)... “ ActOn ” was featured on NewsWatch as ... the latest and coolest applications on the market for iOS, ... technology expert, conducted the app review and shared with viewers ... to make a difference. , In this material world, almost ... aren’t about money, which is why those things should be ...
(Date:5/2/2015)... 02, 2015 On Tuesday April 7th, ... (ELCH) gathered to celebrate improvements in patient care. In ... Partners (RVHP), had zero acquired ventilator associated infections, zero ... infections. ELCH was also recently named a Top Performer ... at ELCH credited the teamwork of staff from all ...
(Date:5/1/2015)... IDLife LLC, a health and wellness company headquartered ... of its newest partner and fitness celebrity, Jen Widerstrom. ... up in gymnastics and competitive diving, but truly found ... trainer and helping others achieve their fitness aspirations. Jen ... highlighting her stunning physique and unique training techniques. ...
(Date:5/1/2015)... May 01, 2015 The Workgroup ... nonprofit authority on the use of health IT to ... key contributing resource to the United States Government Accountability ... electronically readable cards in Medicare. The report, “ Potential ... ” was released to the public on Apr. 24, ...
(Date:5/1/2015)... CA (PRWEB) May 01, 2015 The ... genetic makeup and the interplay of genes with one ... with developments can be daunting. , LabRoots, the premier ... clinical diagnostics professionals, will soon host its annual conference ... At BioConference Live Genetics and Genomics 2015 , ...
Breaking Medicine News(10 mins):Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3
... curious contagious cancer, found in dogs, wolves and coyotes, can ... host animal, according to a new study in the journal ... uncovered an unusual process that helps the cancer survive by ... of the infected animal, to incorporate as its own. They ...
... Gardner HealthDay Reporter , THURSDAY, Jan. 20 (HealthDay ... differently depending on what side of the Atlantic you,re ... flu still predominated in Britain, where 112 people have died, ... some doctors report running out of vaccine, according to the ...
... in Medicine (AIUM) announced today that ultrasound practice accreditation ... the standard for care in fetal echocardiography and builds ... its safe and effective use. "I am proud ... to show that they meet or exceed training and ...
... for your health is not new, but is it really ... Psychological Science , a journal of the Association for Psychological ... influence health outcomes in later adulthood. "We all ... quality of our lives," said Anthony Ong of Cornell University, ...
... A new study published in The American Journal ... (human growth hormone) has become common among young American ... is often associated with polysubstance abuse involving both performance-enhancing ... drug used exclusively by elite athletes, has become cheaply ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... of bedbugs believe they know how the critters become ... drive them from homes, stores and offices across the ... genetic makeup of the bedbug," said lead researcher Omprakash ...
Cached Medicine News:Health News:Contagious cancer thrives in dogs by adopting host's genes 2Health News:H1N1 Flu Is Raging in Britain; Could U.S. Be Next? 2Health News:H1N1 Flu Is Raging in Britain; Could U.S. Be Next? 3Health News:AIUM announces ultrasound practice accreditation in fetal echocardiography 2Health News:Bedbugs Reveal Their Genetic Secrets in Lab Study 2Health News:Bedbugs Reveal Their Genetic Secrets in Lab Study 3
Otoscope with 4X magnification lens, swivellable to both sides, with removable cover glass to insert external instruments. Sealed system allowing for pneumatic otoscopy. 2.5V halogen source....
Designed for instrumentation under magnification. Both lens and speculum can be swivelled. Open construction to allow access and examination under magnification and illumination....
Pocket-sized instrument, powered by two AA-sized alkaline batteries. Built-in throat illuminator, rectangular viewing lens for instrumentation under magnification....
Provides 30% more magnification and twice the field of view. Adjustable focus....
Medicine Products: